In contrast, decreased CCL2 was found in the CSF in all clinical forms of MS by Scarpini et al.[62] More consistently, however, low CCL2 levels were detected only during relapses by others [41,59,61,63,64]. This evidence concerns the gene CCL2 and myeloid sarcoma.